Literature DB >> 26550084

Topographic variability of the left atrium and pulmonary veins assessed by 3D-CT predicts the recurrence of atrial fibrillation after catheter ablation.

Kunihiko Kiuchi1, Akihiro Yoshida1, Asumi Takei1, Koji Fukuzawa1, Mitsuaki Itoh1, Kimitake Imamura1, Ryudo Fujiwara1, Atsushi Suzuki1, Tomoyuki Nakanishi1, Soichiro Yamashita1, Ken-Ichi Hirata1, Gaku Kanda2, Katsunori Okajima2, Akira Shimane2, Shinichiro Yamada2, Yasuyo Taniguchi2, Yoshinori Yasaka2, Hiroya Kawai2.   

Abstract

BACKGROUND: Catheter ablation (CA) is an established therapy for atrial fibrillation (AF). However, the assessment of anatomical information and predictors of AF recurrence remain unclear. We investigated the relationship between anatomical information on the left atrium (LA) and pulmonary veins (PVs) from three-dimensional computed tomography images and the recurrence of AF after CA.
METHODS: Sixty-seven consecutive AF patients (mean age: 62±10 years, median AF history: 42 (12; 60) months, mean LA size: 41±7 mm, paroxysmal: 56%) underwent CA and were followed for 19±10 months. The segmented surface areas (antral, posterior, septal, and lateral) and dimensions (between the anterior and posterior walls, the right inferior PV and mitral annulus [MA], the right superior PV and MA, the left superior PV and MA, and the mitral isthmus) of the LA were evaluated three dimensionally using the NavX system. The cross-sectional areas of the PVs were also evaluated.
RESULTS: After the follow-up period, 49 patients (73%) remained free from AF. A multivariate analysis showed that the diameter of the mitral isthmus and cross-sectional area of the right upper PV were associated with AF recurrence (odds ratio: 1.070, CI: 1.02-1.12, p=0.001; odds ratio: 0.41, CI: 0.21-0.77, p=0.006).
CONCLUSION: Enlargement of the mitral isthmus and a smaller right superior PV cross-sectional area were associated with AF recurrence.

Entities:  

Keywords:  3D-CT, three-dimensional computed tomography; AF, atrial fibrillation; Atrial fibrillation; Catheter ablation; Computed tomography; LA, left atrium; Left atrium; MA, mitral annulus; PV, pulmonary vein; Pulmonary vein

Year:  2015        PMID: 26550084      PMCID: PMC4600931          DOI: 10.1016/j.joa.2015.03.006

Source DB:  PubMed          Journal:  J Arrhythm        ISSN: 1880-4276


  28 in total

1.  Impact of atrial remodeling on the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation.

Authors:  Koichiro Ejima; Ken Kato; Kotaro Arai; Keiko Fukushima; Noritoshi Fukushima; Tsuyoshi Suzuki; Kentaro Yoshida; Toshiaki Nuki; Shoko Uematsu; Hiromi Hoshi; Tetsuyuki Manaka; Kyomi Ashihara; Morio Shoda; Nobuhisa Hagiwara
Journal:  Circ J       Date:  2014-02-21       Impact factor: 2.993

2.  Impact of left atrial volume on outcomes of pulmonary vein isolation in patients with non-paroxysmal (persistent) and paroxysmal atrial fibrillation.

Authors:  Vaibhav Amin; Jonathan Finkel; Ethan Halpern; Daniel R Frisch
Journal:  Am J Cardiol       Date:  2013-07-05       Impact factor: 2.778

3.  Effect of pulmonary vein anatomy and left atrial dimensions on outcome of circumferential radiofrequency catheter ablation for atrial fibrillation.

Authors:  Dennis W den Uijl; Laurens F Tops; Victoria Delgado; Joanne D Schuijf; Lucia J M Kroft; Albert de Roos; Eric Boersma; Serge A Trines; Katja Zeppenfeld; Martin J Schalij; Jeroen J Bax
Journal:  Am J Cardiol       Date:  2011-01-15       Impact factor: 2.778

4.  Morphologic analysis of left atrial anatomy by magnetic resonance angiography in patients with atrial fibrillation: a large single center experience.

Authors:  Matteo Anselmino; Alessandro Blandino; Serena Beninati; Chiara Rovera; Carlo Boffano; Marco Belletti; Domenico Caponi; Marco Scaglione; Federico Cesarani; Fiorenzo Gaita
Journal:  J Cardiovasc Electrophysiol       Date:  2011-01

5.  Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights.

Authors:  Hakan Oral; Bradley P Knight; Mehmet Ozaydin; Aman Chugh; Steve W K Lai; Christoph Scharf; Sohail Hassan; Radmira Greenstein; Jihn D Han; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

6.  Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation.

Authors:  Felipe Bisbal; Esther Guiu; Naiara Calvo; David Marin; Antonio Berruezo; Elena Arbelo; José Ortiz-Pérez; Teresa María de Caralt; José María Tolosana; Roger Borràs; Marta Sitges; Josep Brugada; Lluís Mont
Journal:  J Cardiovasc Electrophysiol       Date:  2013-03-14

7.  Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation.

Authors:  Feifan Ouyang; Dietmar Bänsch; Sabine Ernst; Anselm Schaumann; Hitoshi Hachiya; Minglong Chen; Julian Chun; Peter Falk; Afsaneh Khanedani; Matthias Antz; Karl-Heinz Kuck
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

8.  Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study.

Authors:  Thomas Arentz; Reinhold Weber; Gerd Bürkle; Claudia Herrera; Thomas Blum; Jochem Stockinger; Jan Minners; Franz Josef Neumann; Dietrich Kalusche
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

9.  Pulmonary vein isolation: the impact of pulmonary venous anatomy on long-term outcome of catheter ablation for paroxysmal atrial fibrillation.

Authors:  Alex J A McLellan; Liang-han Ling; Diego Ruggiero; Michael C G Wong; Tomos E Walters; Ashley Nisbet; Anoop K Shetty; Sonia Azzopardi; Andrew J Taylor; Joseph B Morton; Jonathan M Kalman; Peter M Kistler
Journal:  Heart Rhythm       Date:  2013-12-14       Impact factor: 6.343

10.  Computed tomography model-based treatment of atrial fibrillation and atrial macro-re-entrant tachycardia.

Authors:  Christopher Piorkowski; Simon Kircher; Arash Arya; Thomas Gaspar; Masahiro Esato; Sam Riahi; Andreas Bollmann; Daniela Husser; Charlotte Staab; Philipp Sommer; Gerhard Hindricks
Journal:  Europace       Date:  2008-06-23       Impact factor: 5.214

View more
  5 in total

1.  Plasma oxidative stress and inflammatory biomarkers are associated with the sizes of the left atrium and pulmonary vein in atrial fibrillation patients.

Authors:  Jin-Yi Li; Yan He; Hong-Hong Ke; Yu Jin; Zhi-Yuan Jiang; Guo-Qiang Zhong
Journal:  Clin Cardiol       Date:  2017-02-16       Impact factor: 2.882

2.  Anatomical Evaluation of the Pulmonary Veins and the Left Atrium Using Computed Tomography Before Catheter Ablation: Reproducibility of Measurements.

Authors:  Przemysław Ratajczak; Agata Sławińska; Ida Martynowska-Rymer; Piotr Strześniewski; Grażyna Rusak
Journal:  Pol J Radiol       Date:  2016-05-11

3.  Anatomical dilatation of the superior vena cava associated with an arrhythmogenic response induced by SVC scan pacing after atrial fibrillation ablation.

Authors:  Hiroshi Imada; Koji Fukuzawa; Kunihiko Kiuchi; Akinori Matsumoto; Hiroki Konishi; Hirotoshi Ichibori; Kiyohiro Hyogo; Jun Kurose; Shumpei Mori; Tomofumi Takaya; Tatsuya Nishii; Kiyosumi Kagawa; Akihiro Yoshida; Hirata Ken-Ichi
Journal:  J Arrhythm       Date:  2016-10-27

4.  Can an increase in the pulmonary vein volume measured by three dimensional computed tomography predict the presence of atrial fibrillation?

Authors:  Masaaki Kurata; Taku Asano; Hiroyoshi Mori; Hiroshi Mase; Sakura Nagumo; Daisuke Wakatsuki; Hisa Shimojima; Mio Ebato; Akira Miyazaki; Hiroshi Suzuki
Journal:  J Arrhythm       Date:  2019-02-15

5.  Correlation of the peak oxygen consumption and ventilatory aerobic threshold by cardiopulmonary exercise testing with atrial fibrillation recurrences after ablation in patients with paroxysmal atrial fibrillation.

Authors:  Daiki Yamashita; Shigeshi Kamikawa; Ryou Tanaka; Natsumi Tabita; Saori Nishimura; Miyuki Mitsuoka; Shunich Higashiya; Hirosuke Yamaji; Takashi Murakami; Kazuyoshi Hina; Shozo Kusachi
Journal:  J Arrhythm       Date:  2020-05-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.